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Cognitive reserve (CR) may delay cognitive decline during ageing and neurodegenerative 
diseases. The idea has been primarily supported by studies in Alzheimer's disease (AD) 
where CR may maintain the cognitive abilities of patients despite AD neuropathology. 
Parkinson disease (PD) patients often experience significant cognitive decline and dementia, 
so it is possible that CR may also influence the rate of cognitive decline in this disorder. EEG 
metrics are associated with cognitive decline, including in PD. The current study investigated 
the moderating effect of CR on the relationship between the individual alpha frequency (IAF) 
and current cognition in PD. We examined 44 PD patients with relatively normal cognition 
(PDN), 40 PD patients with mild cognitive impairment (PD-MCI) and 28 healthy 
participants. Multiple linear regression was conducted where IAF and a proxy for CR, either 
years of education or premorbid IQ, were used as predictors for cognitive scores. Age and 
gender were used as covariates. Moderation was defined as a significant interaction term 
between IAF and CR in the regression. Neither years of education nor premorbid IQ 
moderated the relationship between IAF values and cognitive ability.  Although these 
findings may reflect the statistical power of the study, they suggest that IAF is a relatively 
robust measure of brain function associated with cognition in PD that is not strongly affected 












Yaakov Stern (2009) proposed the cognitive reserve (CR) theory to explain the discrepancy 
between brain decline and corresponding cognitive decline that can occur in 
neurodegenerative disorders. The CR theory suggests that individuals gain more efficient 
brain function as a consequence of various positive life experiences. Therefore, a brain that 
has experienced relevant environmentally-driven improvements is better able to cope with 
subsequent brain decline, at least to some extent, which is exhibited by the maintenance of 
functions such as cognition despite evidence of neurodegeneration.  
The current study investigated the potential protective effect of CR on cognitive 
abilities in patients with Parkinson’s disease (PD) using EEG as a measure of brain changes. 
Specifically, years of education and premorbid IQ were used as two proxies of CR and a 
stable EEG measure, i.e., individual alpha frequency (IAF), was used as a proxy of brain 
function integrity. The aim was to examine the moderating effect of CR on the relationship 
between IAF and cognitive ability. If such moderation exists, it would support the idea that 
some of the heterogeneity that exists across PD patients may be explained by CR. While 
limited studies have examined the moderation effect of CR in PD, no study has examined this 
relationship using EEG. 
1.1. Parkinson disease  
 
PD is the second most common neurodegenerative disease after Alzheimer’s disease (AD).  
One per cent of the population over the age of 60 is diagnosed with PD (de Lau & Breteler, 
2006). The aetiology of PD is still not known. A PD diagnosis is reliant on an individual 
displaying characteristic motor symptoms, especially bradykinesia with decline in movement 
speed/amplitude overtime after movement initiation, but also classic signs of tremor or 




symptoms are primarily associated with the loss of dopaminergic neurons in the substantia 
nigra pars compacta (Braak et al., 2003). The loss of dopaminergic neurons is associated with 
misfolded alpha-synuclein protein and Lewy bodies. The Braak staging described a bottom-
up model of progressive neurodegeneration in PD (Braak & Del Tredici, 2017). The earliest 
signs of PD-related pathology in the brain is commonly detected in the olfactory bulb and the 
lower brain-stem, particularly the dorsal motor nucleus of the vagal nerve, but there is also 
pathology in the enteric nervous system (Jellinger & Jellinger, 2018). The disease pathology 
spreads in a superior fashion up the brain stem, reaching the substantia nigra and basal 
nucleus of Meynert. Once significant pathology is found in the substantia nigra, then motor 
symptoms emerge that characterize a motor diagnosis of PD (Hawkes, Del Tredici, & Braak, 
2010). 
Severe cognitive impairments also often develop in PD. These are presumed to be related to 
pathology in the mesocortex, allocortex and then eventually the neocortex. Dementia in PD 
(PDD) is a consequence of this stages (Braak & Del Tredici, 2017; Braak, Ghebremedhin, 
Rüb, Bratzke, & Del Tredici, 2004). Better awareness of the frequency and progression of 
cognitive decline has been one of the most significant changes in PD research in recent years 
(Goldman et al., 2018; Weintraub, Tröster, Marras, & Stebbins, 2018). In recognition of this, 
the current definition of PD has shifted from a motor disorder to the broader understanding 
that PD is a progressive neurodegenerative disease that affects multiple neural systems in the 
brain, not just the brain’s motor systems (Baba et al., 1998; Braak & Del Tredici, 2017; Braak 
et al., 2003) 
1.2. Cognitive impairment and dementia 
 
Cognitive impairment has a larger impact on well-being than motor problems and significant 




burden and early mortality (Jones, 2017; Backstrom, 2018). As many as 30-50% of PD 
patients show neuropsychological impairments meeting criteria for PD with mild cognitive 
impairment (PD-MCI) (Litvan et al., 2012; Saredakis, Collins-Praino, Gutteridge, Stephan, & 
Keage, 2019). Patients with a PD-MCI diagnosis have a highly elevated risk of progression to 
dementia, which is much higher than the risk associated with advancing age or 
neuropsychiatric symptoms (Hoogland et al, 2017; Wood et al, 2016). While a substantial 
proportion (50-80%) of all PD patients eventually develop a significant loss of everyday 
cognitive function and independence, triggering a dementia diagnosis (PDD), the rate of 
cognitive decline varies across individuals affected with PD. Moreover, not all PD-MCI 
patients worsen and some even revert to normal cognition (PD-N) status. Such observations 
have been associated with environmental and person-specific factors. For example, being 
tired or stressed at the time of testing will influence testability (Saredakis et al., 2019). 
However, this is probably only a partial explanation of why there is reversion from PD-MCI 
to relatively normal or near-normal cognition.  Similarly, despite PD-MCI being a high-risk 
factor for progression to PDD, we do not know why some people progress quickly while 
others are relatively resilient to further progression. 
 The range of pathophysiological mechanisms associated with progression to PDD is 
yet fully understood. This is partially due to uncertainty regarding the underlying 
neuropathology mechanisms and partly the heterogeneous nature of symptoms expressed by 
patients during the non-dementia period. Lewy bodies, argyrophilic inclusions, 
neurofibrillary tangles, senile plaques, and microvascular disease may all be contributing 
pathological factors in the progression to PDD (Gratwicke, Jahanshahi, & Foltynie, 2015). 
However, the expression of such contributing factors will differ from case to case. This 
matter is complicated further by examples of neuropathology that do not match prior 




corresponds to the later stages of Braak's staging, yet a significant proportion of patients were 
not clinically demented (Burke, Dauer, & Vonsattel, 2008; Gratwicke et al., 2015; Jellinger, 
2009).  
As mentioned, MCI is a common feature for many if not most patients at some point 
in the neurodegenerative process. PD-MCI is the intermediate cognitive stage between 
relatively normal cognition (PD-N) and PDD. In PD-MCI, cognition is below what would be 
expected for the person’s age, but independence and everyday functions are not significantly 
affected. Early detection of PD-MCI provides the opportunity to understand the progression 
of PD and a chance for early intervention to delay PDD onset. However, nearly 24% of PD 
patients may have MCI at the time of diagnosis (Guella et al., 2016), which suggests again 
that other factors than the pattern of neurodegeneration may influence the emergence and 
progression of cognitive decline in PD. 
While it is logical to expect that brain decline would lead to cognitive decline, present 
studies still cannot accurately estimate the severity of cognitive decline based on their disease 
progression in the brain. Due to the lack of in vivo biomarkers for alpha-synuclein, we do not 
know the extent of α-synuclein pathology in patients who do not meet criteria for PDD. The 
situation is different in Alzheimer’s disease (AD), but even for this disorder, we know that 
many subjects must have remained cognitively intact despite widespread β-amyloid 
accumulation (Guzzetti, Mancini, Caporali, Manfredi, & Daini, 2019). The mismatch of 
disease progression and cognitive decline has created difficulty in the search and 
implementation of biomarkers and complicates understanding the process of 





1.3. Cognitive reserve 
 
Cognitive reserve (CR) represents the adaptability of cognitive processes that have been 
gained through life experience such as education, social engagement, occupation and leisure 
activities (Yaakov Stern, 2009; Y. Stern et al., 2018). The CR hypothesis suggests that people 
with higher CR would have a brain that is more efficient, flexible and resilient. Thus, CR 
may partly account for individual differences in terms of disease resilience and protection 
against cognitive decline despite neuropathology. Because CR is a concept that is contributed 
by many factors and experience, it cannot be measured directly and so instead is represented 
by various proxy variables (Y. Stern et al., 2018). The generally accepted proxies are 
education, pre-morbid IQ, occupational complexity, leisure and physical activity. Education 
and pre-morbid IQ are the most popular proxy variables in CR studies (Jones et al., 2011). 
Several studies have reported that more years of education and higher premorbid IQ 
are beneficial factors that may combat cognitive decline in PD (Hindle, Martyr, & Clare, 
2014). This follows studies of normal ageing, where higher education is shown to be 
associated with better cognitive performance. An example of this association in PD is a study 
by Lee et al. (2019). They reported that higher education was positively correlated with 
baseline MMSE, as well as a lower risk of PD progressing past Stage 3 on the Hoehn and 
Yahr scale. Like AD, PD patients with higher pre-morbid IQ are also reported to have fewer 
cognitive impairments than people with low pre-morbid IQ (Koerts, Tucha, Lange, & Tucha, 
2012; Osone, Arai, Hakamada, & Shimoda, 2015). In the absence of a marker for brain 
integrity, however, we do not know whether these associations reflect the specific influence 
of CR. 
In AD, several studies reported that the rate of cognitive decline was slower when 




2019; Xu, Yu, Tan, & Tan, 2015). Yaakov Stern (2012) reported that people showing AD 
neuropathology and with less than 8 years of education were 2.2 times more likely to develop 
dementia than people showing AD neuropathology but more than 8 years of education. Post-
mortem examinations revealed amyloid plaques deposits that would signify probable 
dementia in many cognitively normal older people (van Loenhoud et al., 2019; Xu et al., 
2015). These findings suggest that CR may be related to better maintenance of brain function 
over and above the biological integrity of the brain (Yaakov Stern, 2012; Xu et al., 2015). van 
Loenhoud et al. (2019) found that in non-demented groups, higher CR was associated with a 
slower decline in memory and executive function. They also found that higher CR was 
negatively associated with the risk of conversion to MCI and dementia. Once dementia was 
reached, however, van Loenhoud et al. (2019) reported an accelerated decline in cognition in 
people with high CR, presumably because neural systems had become overwhelmed by the 
severity of neuropathology. Bruandet et al. (2008) also observed an accelerated cognitive 
decline with AD dementia patients that had higher education. They also reported that the 
mortality rate of the ADD groups was unaffected by education. These findings demonstrate 
that CR may no longer compensate for the decline of the brain in the advance stages of AD 
neuropathology and point to the importance of examining CR effects during the earlier stages 
of neuropathology in any disorder.  
Stern et.al (2018) proposed that the optimal way to determine the protective effect of 
CR to examine the moderating effect of CR on the relationship between brain integrity and 
current cognitive ability. To test for the moderation effect of CR, a study should include 3 
components; a measure of the status of the brain, a proxy measure of CR and a measure of 
current cognitive performance. The critical point is that the moderation effect of CR is then 
tested by examining the impact on current cognition of the interaction between brain measure 




measure alone is insufficient evidence to conclude a CR effect because this effect explicitly 
excludes any measure of brain function; it simply reports the unsurprising finding that more 
education, or a higher premorbid IQ, associates with better cognitive performance when 
older.  
Currently, only a small number of studies have incorporated all 3 components in the 
manner proposed by Stern et al. (2018). A search using cognitive reserve and Parkinson as 
keywords yielded 95 results on Scopus and 99 results on PubMed. On closer inspection, 
virtually none of these studies tested for the moderation effect of CR in the context of PD. 
Indeed, Lucero et al. (2015) is the only study to date that has examined the interaction 
between CR and brain measure in the context of PD. They used β-amyloid accumulation as 
the brain measure and found a moderating effect of education between this brain measure and 
current cognition. They reported that the correlation between β-amyloid deposition and 
cognition was only evident for the low education group (years of education < 16). Their 
findings support that higher CR increases functional adaptability and cognitive ‘resilience’ in 
PD, at least with respect to the impact of amyloid pathology.  
Table 1. summarizes a list of non-EEG studies that have incorporated the 3 components, as 
suggested by Stern et.al (2018). In general, CR has been positively associated with various 
aspects of cognitive and brain function. However, some of the studies did not explicitly test 
whether CR moderates the relationship between brain measure and cognitive ability. In one 
study that did do so, Artemiadis et al. (2020) investigated the effect of CR on cognitive 
performance in multiple sclerosis patients. Multiple regression suggested the Expanded 
Disability Status Scale (EDSS; Artemiadis et al. suggests that this measure can be interpreted 
as a biological measure that has both neurological and physical aspects) as the strongest 
predictor of cognition followed by CR (proxy by cognitive reserve index questionnaire, 




exerted a moderating role in the negative association of disability with information 
processing speed. In patients with late-life depression, Lin et al. (2020) found an interaction 
effect between education and white matter hyperintensity for category verbal fluency as an 
outcome variable. McKenzie et al. (2020) found a moderating effect of CR on AD biomarker, 
where it reduces the decline of executive function (EF) in AD patients.  Using a similar 
database as used by McKenzie et al., Bauer, Brown, and Gold (2020) found a positive 
correlation between education and cognitive performance in AD patients. They also found a 
negative effect of AD biomarkers on cognition. However, they did not find a moderation 
effect of education on the relationship between AD biomarkers and cognitive performance. 
One thing to note is that McKenzie et al used the database of Alzheimer’s Disease 
Neuroimaging Initiative 1 and 2, whereas Bauer et al only used Alzheimer’s Disease 
Neuroimaging Initiative 1. Hence McKenzie et. al. used almost triple the number of subjects 
compared to the study by Bauer et al. (2020).  Franzmeier et al. (2016) found a positive 
correlation between education and cognitive performance in AD patient. However, they did 
not examine the interaction between CR and a brain measure. In frontotemporal dementia 
study, Premi et al. (2020) looked at the correlation between metastate global dynamic fluidity 
(brain measure obtained from MRI) and education which they found to be significant. They 
also found that higher education patient. 
with comparable clinical severity would express more global functional connectivity.  They 
did attempt to investigate the moderation effect of CR in their study. Across different studies 
using the “3-variable” rule, conflicting findings have been presented for the moderating effect 
of CR in the literature. Further research is needed to understand the impact of CR on 
cognitive resilience in PD because thus far there is only one study that directly tests the 





Table 1. Non-EEG CR studies that included a brain measure, CR measure and cognitive outcome.  
* the United Kingdom Parkinson's Disease Society Brain Bank clinical diagnostic criteria; **frontotemporal dementia Multiple sclerosis; ***White matter 
hyperintensity
Name N Diseases Proxy Method Statistical method Disease diagnosis method Neuropsychological assessment Moderat
ion 
found? 
Lucero et al. 
(2015) 
















years of formal 
education 
 
fMRI Linear regression Amyloid-PET positive= of global 
[18F] AV-45 PET standardized uptake 
value ratio >1.11 
CERAD word list learning tests Rey Auditory 
Verbal Learning Test (RAVLT) 
No 






MRI Partial Pearson's 
correlation 
Clinical diagnostic criteria of 
behavioural variant frontotemporal 
dementia 














Linear regression 2011 revised McDonald Multiple 
sclerosis criteria 
Symbol Digits Modalities Test (SDMT), 
California Verbal Learning Test II (CVLT-II), 
Brief Visuospatial Memory Test-Revised 




Bauer et al. 
(2020) 
441 AD Years of 
education 
MRI Linear mixed models Reported memory concern, Abnormal 
memory function score on Wechsler 
Memory Scale; Mini-Mental State 
Exam (MMSE) score of 20-26 (24-30 
for MCI); Clinical Dementia Rating 
(CDR) = 0.5(MCI) or 1.0 
Composite longitudinal memory and/or 
executive function from the original study 
(MMSE, etc.) Alzheimer’s Disease 
Neuroimaging Initiative 2 
No 







MRI Structural equation 
model 
Same as above  Same as above Yes 





MRI Linear regressions DSM-5 major depressive disorder 
criteria, WMH was quantified using 
the fuzzy connectedness segmentation 
algorithm on WM lesions fromT2-
FLAIR images 
MMSE, digit symbol substitution test (DSST), 






1.4. Electroencephalograph  
 
The electroencephalogram (EEG) was conceptualized in the late 19th century. It was first 
used in sleep studies in the 1930s and its popularity has increased immensely recently. EEG 
has been used to address brain function and cognitive function in healthy people and many 
disorders (Amato, Caverzasio, & Galati, 2020). EEG is a non-invasive and low-cost method 
to generate information on brain activity. EEG uses electrodes on the scalp to monitor and 
record electrical activity generated by cortical layers of the brain, to continuously monitor 
brain activity with a high temporal resolution in the order of milliseconds. Because of the 
non-invasive, high-temporal resolution, and simple setup properties of EEG, studies can 
introduce stimuli more freely than methods that use large machinery such as magnetic 
resonance imaging (MRI) and positron emission tomography (PET) (Chaumon, Crouzet, & 
Busch, 2015; Wagner, Chaves, & Wolff, 2017). Therefore, EEG is a suitable choice in 
studies that monitor brain activity involving fragile populations such as PD and AD patients.  
EEG has been robustly linked to age and disease-related brain decline (Benz et al., 
2014). It is widely reported that a slowing down of EEG alpha rhythm occurs with ageing, 
which is accelerated with cognitive decline. During resting-state wakefulness, cognitive 
decline has been found to be associated with the increase of EEG power in theta and delta 
bands but a reduction of power in alpha and beta bands (C. Babiloni et al., 2018; Stoffers et 
al., 2007).  In PD and AD, the slower alpha rhythm has been detected before signs of 
cognitive decline, suggesting EEG as a measure of brain integrity rather than a direct 
reflection of cognitive ability (Benz et al., 2014; Smit, Wright, Hansell, Geffen, & Martin, 
2006).  
The use of EEG to study CR has been limited. Table 2 summarizes studies that used 




the effect of education level in presumed AD patients showing subjective memory complaints 
(SMC). The study tested for the moderation effect of education on SMC to predict power 
density, which is conceptually similar to the reverse in which cognition is the outcome 
variable. Power density is a measure of the amount of brain activity in a frequency band, as a 
representation of brain integrity. The study found that that education moderates the 
relationship between SMC and power density in the non-SMC group but not in SMC group. 
In the non-SMC group higher education was associated with higher posterior alpha power in 
the parietal, occipital and temporal brain region. In the SMC group, higher education was 
only associated partially (only in alpha 3 band instead of the whole range of alpha) in the 
temporal region. Babiloni et al. (2020) suggested this the inconsistency of alpha power 
between the two groups was due to the failure of CR, where CR’s compensatory effect could 
not sufficiently cope with the brain decline in the SMC group.  
Amodio, et al. (2017) found that cognitive decline was positively correlated with the 
psychometric hepatic encephalopathy score (PHES, a test for cognitive impairment) in 
hepatic encephalopathy patients. They found that higher CR maintain their PHES (delay 
cognitive decline). However, they found no association between PHES and any of the EEG 
measures (Mean Dominant Frequency, alpha, beta, delta, and theta power). They suggested 
that EEG is more reflective of neurophysiologic assessments instead of cognitive 
assessments. Gu et al. (2018) reported a positive correlation between CR and neural 
efficiency and task reaction time in Amnestic MCI patients. They defined neural efficiency as 
the “degree to which a task-related brain network must be activated to fulfil the task”. Task-
related neural processing (P300 amplitude/latency) was used to derive a neural inefficiency 
score (an inversed neural efficiency measure). They found a positive association between CR 
and neural efficiency. Fleck et al. (2017) examined the impact of age and CR on brain 




connectivity) in younger participants and an increase of mean coherence in older participants. 
Fleck et al. proposed that the low mean coherence in younger participants with CR may be a 
result of better network efficiency and the increase in older participants may be the 
compensation effect. The most relevant finding in this study was the interaction effect for age 
and CR on brain coherence. Although not a traditional cognitive performance measure, brain 
connectivity has been associated with cognitive performance (Kranczioch, 2017; Vecchio et 
al., 2016). Therefore, the finding suggests that CR could benefit cognitive performance 
through the moderation of the impact of ageing.  
To the best of author's knowledge, no study examined the moderation effect of CR in 
PD using EEG. Individual alpha frequency (IAF) is a suitable EEG brain measure derived 
from EEG signals. IAF is the frequency of peak power in the extended alpha band (i.e. 5-14 
Hz) (Goljahani et al., 2012; Haegens, Cousijn, Wallis, Harrison, & Nobre, 2014). An 
individual's IAF increases from childhood to adulthood and then decreases with age. This is 
thought to mimic brain development and decline (Haegens et al., 2014). In twin studies, the 
heritability estimates of IAF is about 80% showing that IAF is strongly influenced by genetic 
factors (Goljahani et al., 2012; Haegens et al., 2014). With the relation to age and genetics, 
IAF is less likely to be a direct measure of cognitive ability but rather a direct measure of 





Table 2. CR studies with EEG as brain measure. 
*Psychometric Hepatic Encephalopathy Score**National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer’s Disease 
and Related Disorders Association 
















With a 1-8 
scale 
ANOVA positive amyloid β 
deposition on 18F-
florbetapir and 




(MMSE) score ≥ 27 
and Clinical 
Dementia Rating 
score (CDR) = 0 for 
cognitively normal 
 
posterior rsEEG power density 
at the individual 















ANCOVA Clinical diagnose of 
cirrhosis 
PSE syndrome test* Mean Dominant Frequency, 
relative power of the 
theta band, the relative power 
of delta band 
 
No 
Gu et al. 
(2018) 
84 Amnestic MCI CRIq ANCOVA 
and 
RMANOVA 

















Mean P300 amplitudes, No 
Fleck et al. 
(2017) 




ANOVA  MMSE-2, Clock 




and other various 
neuropsychological 
assessments 
Mean coherence of delta, theta, 








Thus far, the moderating effect of CR on the relationship between cognition and brain 
measure has been investigated in the context of PD only once and never using EEG. The 
current study aimed to determine the moderating effect of CR on the relationship between a 
stable EEG measure and cognitive ability. The individual alpha frequency (IAF) was used as 
a suitable EEG metric; education and premorbid IQ were used as two separate proxy 
measures of CR. CR proxies were expected to have significant interaction with IAF in 
predicting cognitive performance. That is, for similar IAF values, participants with higher 
education and/or premorbid IQ should have higher cognitive scores compared to those with 
lower CR.  
2. Method 
 
2.1. Participants  
 
This study was based on an ongoing EEG study from New Zealand Brain Research Institute 
(NZBRI). The collection of EEG data was mainly done by trained colleagues at the NZBRI, 
especially Emma Peterson. The author is familiar with the process and collected EEG from a 
few participants. The author is familiar with the process and collected EEG from a few 
participants, although further involvement was curtailed by Covid-19 restrictions during 
2020. The participants were recruited from the participant pool of an ongoing longitudinal 
study based at the NZBRI. Before recruitment for the current EEG study, the NZBRI cohort 
had already been selected. Exclusion criteria included significant psychiatric history (e.g. 
current diagnosis of schizophrenia, bipolar affective disorder or histories that warranted 
hospitalization), a significant past or current substance abuse or dependence (alcohol 
included), a moderate or severe traumatic brain injury, history of learning disability or 




additional exclusion criteria. The participant was excluded if they had unremovable metal 
objects in the skull and neck area and/or a non-corrected severe sight problem (e.g. partial 
blindness). They were also required to have detailed neuropsychological testing within 6 
months of the EEG session.  
The diagnosis of the PD participants was based on the UK Parkinson’s Society 
criteria (Hughes, Daniel, Kilford, & Lees, 1992) supplemented by MDS criteria (Postuma et 
al., 2015). The PD participants were classified as showing cognition in the normal range for 
their age (PD-N), PD with mild cognitive impairment (PD-MCI) or PD dementia (PDD), 
based on the Movement Disorders Society (MDS) task force level II criteria (Postuma et al., 
2015). Cognitive assessment was based on an abbreviated selection of neuropsychological 
tests (10 tests) found by the NZBRI to provide good longitudinal (4-year) prediction of 
progression from PD-MCI to PDD (D. J. Myall et al., 2020). The neuropsychological tests 
provided 2 measures in each of 5 cognitive domains, thereby fulfilling Level II criteria for 
PD-MCI if two impairments existed, in our case, at -1.5SD below normative scores (Litvan et 
al, 2012; Table1). The PDD criteria (Dubois et al 2007) required significant impairments (-2 
SD below the normative mean) in at least two cognitive domains that are causal for 
significantly impaired everyday cognitive function not attributed to motor impairments; in the 
current study, a PDD diagnosis was ascertained prior to the study but PDD status was verified 
closer to the EEG session using the MoCA and information from a significant other. 
However, very few patients with PDD were able to provide data on the 10 
neuropsychological test measures and were not examined further. That is, the current study 





Figure 1. Exclusion process of PD and HC participant groups 
 
A total of 163 participants, including 39 healthy controls (HC), were recruited from 
the NZBRI longitudinal cohort’s database via phone calls from the Research Coordinator. Of 
those, 159 participants completed comprehensive neuropsychological testing. The PD group 
had 120 cases; 10 cases were excluded for not having neuropsychological testing within 6 
months of the EEG session. 15 PD cases were excluded due to artefacts interference in the 
EEG data. Thus 95 cases remained in the PD group after exclusion, 44 PD-N, 40 MCI and 11 
PDD (PDD excluded for reasons above). The HC group had 39 cases, 3 were excluded for 
incomplete neuro-psychological testing and 8 were excluded for to artefacts interference in 
the EEG data. Figure 1. describes the flowchart for participants. 
2.2. Neuropsychological tests 
 
The neuropsychological data were gathered by research assistants during sessions that were 




test sessions. The sessions collected demographic information, the Unified Parkinson’s 
disease rating scale (UPDRS III), the Hoehn and Yahr stage (HY), Montreal Cognitive 
Assessment (MoCA), the Clinical Dementia Rating scale (CDR), and premorbid IQ using the 
Wechsler Test of Adult Reading (WTAR) test. Although 21 neuropsychological test 
measures were routinely collected, we focus here on a battery of 10 neuropsychological tests 
(10 tests) across five cognitive domains that have found to have the strongest predictive value 
for conversion to PDD within 4 years, which therefore were used to determine a determine 
PD-MCI status (D.J. Myall et al., 2020). The 10 tests are listed in Table 3. A global Z score 
of the 10 tests was calculated by averaging scores across these 10 tests. To ensure the EEG 
data gathered was an accurate representation of cognitive ability, participants that had not 
received neuropsychological tests within 6 months of the EEG session were excluded.  
Table 3. The 10test neuropsychological tests across 5 cognitive domains. 
Domain Pair of Tests per Domain  
Executive Function Trail Making part B Stroop interference 
Attention, working memory & 
processing speed 
TEA Map Search first minute Digit ordering 
Episodic memory CVLT-II SF total immediate recall RCFT immediate recall 
Visuo-perceptual Judgement of line orientation RCFT copy 











2.3.1. EEG Data Acquisition 
 
Participants attended a two-hour EEG session at the NZBRI EEG lab in Christchurch. They 
were asked to perform a series of conditions in front of a computer screen while their brain 
activity was being recorded. The EEG data were gathered using a 64-channel EEG cap 
(Quick-Cap, Compumedics Neuroscan) with Ag/AgCl electrodes. A Neuroscan SynAmps 2 
amplifier (24 bit) was used to amplify and digitize EEG signals. The Curry 7 software 
(Compumedics Neuroscan) was used to record the EEG data. The gap between EEG 
electrodes and the scalp was filled with conductive gel. The vertical electrooculogram 
(VEOG) was also recorded by placing two electrodes above and below the right eye. Mastoid 
electrodes were placed on the right and left mastoid bones. The impedance of the electrodes 
was kept below 10 kΩ. EEG was collected during an eyes-closed resting-wakefulness 
session. Participants were asked to close their eye and relax for 9 mins while staying awake. 
To ensure wakefulness, the task was interrupted every 3 min and participants were asked to 
open their eyes. After each session, the EEG cap was cleaned and disinfected. The testing 
paradigm has been developed by the team from the New Zealand Brain Research Institute 
(NZBRI).  
2.3.2. Individual alpha frequency 
 
PrepPipeline plugin in EEGLAB was used to remove line noise and identify bad electrodes 
(Bigdely-Shamlo, Mullen, Kothe, Su, & Robbins, 2015; Delorme & Makeig, 2004; Delorme 
et al., 2011). The EEG data were then band-pass filtered between 1 and 80 Hz using a finite 
impulse response (FIR) zero-phase filter. Stereo-typical artefacts were minimised using 
infomax independent component analysis, where artefactual components were identified 




Sejnowski, & Makeig, 2007; Nolan, Whelan, & Reilly, 2010; Pion-Tonachini, Kreutz-
Delgado, & Makeig, 2019). Canonical correlation analysis blind source separation was used 
to minimise muscle activity on the EEG data. EEG pre-processing was followed by applying 
artefact subspace reconstruction (ASR) with k=5 to minimise the remainder of artefacts 
(Clercq, Vergult, Vanrumste, Van Paesschen, & Van Huffel, 2006; Mullen et al., 2015). 
Rejected electrodes were interpolated using spherical spline method in EEGLAB. Surface 
Laplacian was applied to remove the volume conduction (Tenke, Kayser, Abraham, 
Alvarenga, & Bruder, 2015). EEG processing was conducted by Dr Reza Shoorangiz. 
The clean EEG data excluding the 10 seconds epoch around wakefulness checks were 
segmented into 2-second epochs. Epochs were removed if they were affected by any artefacts 
such as movement or ocular artefacts. Hanning window was applied to the epoch to avoid 
edge artefacts.  Spectral power was calculated using fast Fourier transform (FFT) to provide 
the power density of scalp resting-state EEG (rsEEG) rhythms with 0.5 of frequency 
resolution, taken from the posterior scalp electrodes. The extended alpha range chosen was 
IAF 5Hz to 14Hz, where IAF was taken as the maximum power density peak within this 
extended alpha range. 
2.4. Ethics  
 
The current study was approved by a local ethics committee of the New Zealand Ministry of 
Health (ethics ref: URB/09/08/037/AM19). 
2.5. Statistical analysis 
 
Statistical analysis was performed by Tim Xie with assistance from Dr Reza Shoorangiz, 
using the open-source software R (V4.0.1; http://CRAN.R-project.org/doc/).  Group 
differences of IAF were compared by a one-way ANOVA. The moderation effect of CR on 




regression analyses. Each analysis was performed for each of the CR proxies (x2) and 
cognitive scores (x12). That is, CR proxy (education or premorbid IQ), IAF and the 
interaction between and IAF and CR proxy were used as the predictors of MoCA, global Z 
score of the 10 tests and the Z score of individual tests (see Table 3.). Age and gender were 
included in the linear models as covariates. Premorbid IQ was based on the WTAR. Effect 




















3.1. Demographics and group differences 
 
Demographic information is summarized for the PD-N, PD-MCI, and HC groups (Table 4). 
MoCA data was education-adjusted when retrieved from the longitudinal data set, so it was 
reverted to the raw score. Participants had more than one WTAR (premorbid IQ) score over 
time, which had not been previously investigated by the NZBRI. To determine the stability of 
this premorbid IQ measure, Pearson correlations were performed with the obtained median of 
WTAR relative to the mean of WTAR (r = 0.99. p<0.01, n =123), and between median 
WTAR and the first WTAR assessment (r = 0.98, p<0.01, n= 123). These strong correlations 
indicated the robustness of WTAR scores over time. For the current study, the median score 
of WTAR was chosen as a proxy of CR.  
Table 4. Demographics table of all participants. 
  Control PD-N PD-MCI 
Sample size  28 44 40 
Male/Female 19/9 26/18 29/11 
Mean age (SD) 75.68 ±7.72 68.39 ±7.25 72.33 ±6.2 
Mean Symptom duration – 9.56 ±5.64 12.85 ±6.37 
Mean years of Education 13.71 ±2.48 13.23± 2.34 12.68 ±2.52 
Mean WTAR (SD) 114.2±7.56 112.2 ±9.04 109 ± 8.11 
Mean IAF (SD) 8.93±0.78 8.69 ±1.07 7.85 ± 1.3 
Mean UPDRS (SD) – 28.6 ±12.05 42.41 ± 12.63 
Mean HY (SD) – 2.21 ±0.47 2.56 ±0.48 
Mean LEDD (SD)* – 933 ±1229 1015 ±528.1 
Mean global Z (10 tests) (SD) 0.77 ±0.41 0.17 ±0.42 -0.99 ±0.56 






Figure 2. boxplot showing the distribution of IAF in the control, PD-N and PD-MCI groups. Points 
represent individual IAF of each participant; n=112. 
 
The distribution of IAF across the three groups is described in Figure 2. ANOVA 
showed a significant difference in IAF among the 3 groups (F (2,107) = 9.73, p<0.001). 
Tukey post hoc pair-wise comparisons (Figure 3. for relative to HC group) revealed that the 
IAF of the control group was significantly higher than that of the PD-MCI group, but not 
significantly different to the PD-N group. The PD-N group's IAF values were also 
significantly higher than those in the PD-MCI group.  
 
 
Figure 3. Pairwise comparison between control, PD-N and PD-MCI groups. Redline represents the 
corresponding reference group (the first group specified) relative to the comparison (the second 





3.2. IAF and education as predictors of cognitive ability in the education model 
 
When education was used as the proxy of CR, IAF was significantly associated with all 
cognitive measures. The largest main effect of IAF was found with TEA Map Search 1 min 
as the outcome (dependent) variable (β = 0.46, p < 0.001, f= 0.53 [0.3, 0.74]). The smallest 
main effect of IAF was observed for MoCA (β = 0.198, p = 0.028,  f= 0.216 [0.00, 0.41]). 
IAF was also moderately associated with Global Z (β = 0.435, p <0.001, f= 0.478 [0.3, 0.68]) 
(see Table 5.) 
Table 5. Main effect of IAF on cognitive scores with age and gender as covariates in the education 
model. 
Statistical significance, p < 0.05: IAF are significantly associated with all cognitive scores. B 
represents the unstandardized beta value. Note: Cohen’s f interpretation: 0.14 = small, 0.39 = 
medium, 0.59 = large. 
 
By contrast, years of education was not significantly associated with the Global Z score. 
However, years of education was found to show a weak but significant association with TEA 
Cognitive measure  B β t p Cohen’s f  [CI] 
Global Z score 0.311 0.435 4.805 0 0.478 [0.3, 0.68] 
Trail Making part B 0.34 0.299 3.271 0.001 0.318 [0.12, 0.51] 
Stroop interference 0.384 0.378 4.148 0 0.403 [0.2, 0.60] 
TEA Map Search 1 min 0.46 0.463 5.36 0 0.53 [0.3, 0.74] 
Digit ordering 0.278 0.237 2.514 0.013 0.245 [0.05, 0.44] 
CVLT-II SF total immediate recall 0.419 0.334 3.707 0 0.361 [0.2, 0.56] 
RCFT immediate recall 0.378 0.286 3.089 0.003 0.302 [0.1, 0.50] 
Judgement of line orientation 0.198 0.244 2.598 0.011 0.253 [0.06, 0.45] 
RCFT copy 0.353 0.33 3.654 0 0.357 [0.16, 0.55] 
Mattis DRS-2: similarities 0.164 0.263 2.789 0.006 0.271 [0.08, 0.46] 
ADAS-Cog: language 0.228 0.355 4.065 0 0.397 [0.2, 0.59] 




Map Search 1 min, CVLT-II SF total immediate recall, RCFT copy and MoCA scores (see 
Table 6.).  
Table 6. Main effect of education on cognitive scores with age and gender as covariates. 
Statistical significance, p < 0.05: Global Z score, TEA Map Search 1 min, CVLT-II SF total 
immediate recall, RCFT copy and MoCA were significantly associated with years of education. B 
represents the unstandardized beta value. Note: Cohen’s f interpretation: 0.14 = small, 0.39 = 
medium, 0.59 = large. 
 
3.3. IAF and premorbid IQ as predictors of cognitive ability in the pre-morbid IQ 
model 
 
When premorbid IQ was used as the proxy of CR, IAF was again significantly associated 
with all cognitive measures (see Table 7.). Consistent with the education model, TEA Map 
Search 1 min had the largest association with IAF (β = 0.469, p < 0.001, f = 0.537 [0.3, 
0.74]). Similarly, MoCA had the smallest association with IAF (β = 0.22, p = 0.009 f = 0.259 
[0.06, 0.45]). The association of IAF and global Z score was also moderate (β = 0.445, p 
<0.001, f = 0.507 [0.30, 0.72]).  
 
Cognitive measure  B β t p Cohen’s f [CI] 
Global Z score 0.052 0.146 1.646 0.103 0.13 [0.0, 0.33] 
Trail Making part B 0.039 0.072 0.795 0.428 0.082 [0.00, 0.27] 
Stroop interference 0.048 0.098 1.095 0.276 0.104 [0.0, 0.29] 
TEA Map Search 1 min 0.085 0.176 2.062 0.042 0.188 [0.0, 0.38] 
Digit ordering -0.023 -0.04 -0.43 0.668 0.055 [0.00, 0.24] 
CVLT-II SF total immediate recall 0.109 0.18 2.016 0.046 0.187 [0.0, 0.38] 
RCFT immediate recall 0.065 0.101 1.105 0.272 0.104 [0.0, 0.30] 
Judgement of line orientation 0.069 0.176 1.902 0.06 0.181 [0.00, 0.37] 
RCFT copy 0.125 0.241 2.698 0.008 0.259 [0.06, 0.45] 
Mattis DRS-2: similarities 0.038 0.126 1.354 0.178 0.136 [0.00, 0.33] 
ADAS-Cog: language 0.002 0.006 0.065 0.948 0.005 [0.0, 0.09] 




Table 7. Main effect of IAF on cognitive scores with age and gender as covariates in the pre-morbid 
IQ model. 
Statistical significance, p < 0.05: IAF are significantly associated with all cognitive scores. B 
represents the unstandardized beta value. Note: Cohen’s f interpretation: 0.14 = small, 0.39 = 
medium, 0.59 = large. 
 
Unlike years of education, The WTAR score was significantly associated with the 
Global Z score. The WTAR score was also significantly associated with Stroop interference, 
Digit ordering, CVLT-II SF total immediate recall, Judgement of line orientation and RCFT 





Cognitive measure  B β t p Cohen’s f  [CI] 
Global Z score 0.316 0.445 5.048 0 0.507 [0.30, 0.72] 
Trail Making part B 0.347 0.306 3.365 0.001 0.327 [0.13, 0.52] 
Stroop interference 0.393 0.387 4.341 0 0.423 [0.2, 0.62] 
TEA Map Search 1 min 0.466 0.469 5.385 0 0.537 [0.3, 0.74] 
Digit ordering 0.29 0.247 2.639 0.01 0.257 [0.06, 0.45] 
CVLT-II SF total immediate recall 0.436 0.348 3.901 0 0.38 [0.18, 0.58] 
RCFT immediate recall 0.388 0.293 3.185 0.002 0.311 [0.1, 0.51] 
Judgement of line orientation 0.211 0.26 2.846 0.005 0.276 [0.08, 0.47] 
RCFT copy 0.368 0.343 3.849 0 0.376 [0.18, 0.57] 
Mattis DRS-2: similarities 0.17 0.272 2.886 0.005 0.28 [0.08, 0.47] 
ADAS-Cog: language 0.232 0.36 4.152 0 0.405 [0.2, 0.60] 




Table 8. Main effect of pre-morbid IQ on cognitive scores with age and gender as covariates. 
Statistical significance, p < 0.05: Global Z, Stroop interference, Digit ordering, CVLT-II SF total 
immediate recall, Judgement of line orientation and RCFT copy were significantly associated with 
WTAR score (pre-morbid IQ). B represents the unstandardized beta value. Cohen’s f interpretation: 
0.14 = small, 0.39 = medium, 0.59 = large. 




The Moderation effect of CR on the relationship between scores of neuropsychological tests 
and IAF is summarized in Table 9. All analyses were adjusted for age and gender as 
covariates. There was no evidence of a moderating effect on education. However, the small 
moderating effect approached significance for Stroop interference and Digit ordering test. 
Importantly, similar conclusions were found when performing the same analyses with only 
the PD participants (i.e., without including HC). Removing the age and/or gender from the 
analyses did not change the results. 
Cognitive measure  B β t p Cohen’s f [CI] 
Global Z score 0.027 0.266 3.081 0.003 0.279 [0.08, 0.48] 
Trail Making part B 0.021 0.134 1.484 0.141 0.131 [0.00, 0.32] 
Stroop interference 0.026 0.188 2.122 0.036 0.194 [0.0, 0.39] 
TEA Map Search 1 min 0.018 0.129 2.122 0.145 0.130 [0.0, 0.32] 
Digit ordering 0.032 0.197 2.131 0.035 0.201 [0.00, 0.39] 
CVLT-II SF total immediate recall 0.043 0.246 2.78 0.006 0.258 [0.06, 0.45] 
RCFT immediate recall 0.027 0.146 1.601 0.112 0.145 [0.0, 0.34] 
Judgement of line orientation 0.033 0.293 3.236 0.002 0.302 [0.11, 0.50] 
RCFT copy 0.041 0.275 3.104 0.002 0.289 [0.09, 0.48] 
Mattis DRS-2: similarities 0.013 0.152 1.631 0.106 0.141 [0.00, 0.33] 
ADAS-Cog: language 0.009 0.101 1.174 0.243 0.091 [0.0, 0.28] 




 Figure 4. represents the interaction between years of education and IAF to estimate 
the Global Z. The fitted lines are derived from the statistical model to show the minimum, 
lower quartile, median, upper quartile, and the maximum of years of education. The graph 
suggests that as the years of education increases, higher IAF are more associated with the 
Global Z score. Therefore, the graph suggests a small trend of interaction between years of 
education and IAF, but the interaction effect did not approach significance. 
Table 9. Moderation effect of years education on the relationship between cognition and IAF adjusted 
for age and gender. 
Results of the interaction between years of education and IAF. At the standard significance level of p 
= 0.05, no significant interaction was obtained across any of the cognitive scores. B represents the 
unstandardized beta value. Cohen’s f interpretation: 0.14 = small, 0.39 = medium, 0.59 = large. 
 
Cognitive measure  B β t p Cohen’s f [CI] 
Global Z score 0.027 0.092 1.016 0.312 0.102 [0.0, 0.30] 
Trail Making part B -0.019 -0.041 -0.453 0.652 0.044 [0.00, 0.23] 
Stroop interference 0.067 0.163 1.921 0.058 0.189 [0.0, 0.38] 
TEA Map Search 1 min 0.021 0.05 0.555 0.58 0.054 [0.0, 0.24] 
Digit ordering 0.086 0.179 1.913 0.058 0.186 [0.00, 0.38] 
CVLT-II SF total immediate recall 0.067 0.131 1.46 0.147 0.142 [0.0, 0.33] 
RCFT immediate recall 0.032 0.058 0.634 0.528 0.062 [0.0, 0.25] 
Judgement of line orientation 0.023 0.068 0.732 0.466 0.071 [0.00, 0.26] 
RCFT copy 0.029 0.065 0.726 0.469 0.071 [0.00, 0.26] 
Mattis DRS-2: similarities -0.01 -0.038 -0.403 0.688 0.039 [0.00, 0.22] 
ADAS-Cog: language 0.009 0.032 0.375 0.709 0.037 [0.0, 0.22] 





Figure 4. Interaction between years of education and IAF predicting average Z score of the cognitive 
10test (global Z). Points represent raw data. Fitted lines are adjusted for gender and age derived 
from the model, with lines corresponding to a model-derived minimum, lower quartile, median, upper 
quartile, and the maximum of years of education.   
3.4.2. Premorbid IQ 
 
The moderation effect of WTAR on the relationship between IAF and cognitive scores, 
adjusted for age and gender, is summarized in Table 10. There was no evidence of a 
moderating effect of WTAR on the association between IAF and the score of cognitive tests. 
Only Stroop interference as the cognitive outcome suggested even a weak effect. Similar 
results were also obtained without adjusting for age and/or gender. The results remained non-
significant after excluding the HC group. The interaction term of IAF by WTAR for the 








Table 10. moderation effect of WTAR score on the relationship between IAF and cognitive scores, 
adjusted for age and gender. 
Results of the interaction between WTAR and IAF. At the standard significance level of p = 0.05, no 
significant interaction was obtained across any of the cognitive scores. B represents the 
unstandardized beta value. Cohen’s f interpretation: 0.14 = small, 0.39 = medium, 0.59 = large. 
 
Figure 5. Interaction between WTAR and IAF predicting average Z score of the 10 cognitive tests. 
Points represent raw data. Fitted lines are based on the model adjusted for gender and age. The 5 
lines correspond to the minimum, lower quartile, median, upper quartile, and maximum of WTAR, 
derived from the model.  
Cognitive measure  B β t p f  [CI] 
Cognitive 10 test Z score 0.006 0.077 0.85 0.397 0.085 [0.00, 0.28] 
Trail Making part B 0.006 0.042 0.445 0.657 0.043 [0.00, 0.23] 
Stroop interference 0.02 0.168 1.855 0.066 0.183 [0.0, 0.38] 
TEA Map Search 1 min 0.013 0.108 1.168 0.245 0.113 [0.0, 0.30] 
Digit ordering 0.013 0.093 0.955 0.342 0.093 [0.00, 0.28] 
CVLT-II SF total immediate recall 0.011 0.075 0.813 0.418 0.079 [0.00, 0.27] 
RCFT immediate recall 0.007 0.044 0.457 0.648 0.045 [0.0, 0.23] 
Judgement of line orientation 0.001 0.009 0.1 0.921 0.01 [0.00, 0.15] 
RCFT copy 0.006 0.052 0.554 0.581 0.054 [0.00, 0.24] 
Mattis DRS-2: similarities -0.004 -0.06 -0.613 0.541 0.06 [0.00, 0.25] 
ADAS-Cog: language -0.003 -0.044 -0.489 0.626 0.048 [0.0, 0.24] 






4.1. Findings  
 
This study aimed to investigate the moderating effect of CR on the relationship between an 
EEG brain measure and cognition. Examining the moderating effect of CR on the association 
between cognition and brain integrity could help us understand the coping mechanisms of the 
brain when experiencing neurodegeneration and thus contribute to reasons why there is 
variation in cognitive decline across different PD patients. This would ultimately facilitate 
finding a reliable marker of cognition in PD and perhaps assist in detecting premorbid PD. 
However, with education and premorbid IQ the proxies of CR, there was no evidence of a 
moderating effect for CR on the association between IAF and scores on cognitive tests in a 
group of HC and PD patients. Similar results were found when the moderation effect was 
investigated only in the PD participants (i.e., HC excluded). The IAF differences among the 3 
groups and the significant association between IAF and cognitive scores was expected; there 
was a decrease of IAF associated with cognitive decline (Benz et al., 2014). The lack of a 
moderating effect of CR on the relationship between IAF and cognitive scores suggests that 
CR does not have a protective effect on cognitive ability or that IAF is a specific brain 
measure that is resistant to the effects of CR.  
Education, by itself, was not associated with the Global Z score. Some specific 
measures, such as TEA Map Search 1 min, CVLT-II SF total immediate recall, RCFT copy 
and MoCA did show weak but significant associations with education. Education has been 
consistently reported to be related to improved cognition since childhood and delayed 
cognitive decline (Bauer et al., 2020; Clouston et al., 2019). In PD studies, higher education 
is associated with better bassline motor and cognitive function. Higher education individuals 




et al., 2019). However, longer education does not necessarily equate to a CR effect per se in 
that there is no differential effect of high or low education with respect to EEG IAF as a brain 
measure using the criteria of Stern et al. (Y. Stern et al., 2018). Many of the previous studies 
suggesting a CR effect in PD only looked at the simple association between education and 
cognition without considering brain metrics. With the current study focusing on the cognitive 
impairment aspect of PD, different levels of education would maintain different levels of 
cognition but irrespective of brain decline relevant to non-dementia in PD.  
Pre-morbid IQ had a significant relationship with the global Z score based on the 10 
neuropsychological test measures. It was also associated with most of the cognitive domains 
except language. Although they are not the same, the relationship between pre-morbid IQ and 
cognitive abilities is to be expected. The inconsistency in the current research is the language 
domain. Like other cognitive domains, previous research has provided evidence the language 
is associated with premorbid (Mohn, Sundet, & Rund, 2014; Schretlen, Buffington, Meyer, & 
Pearlson, 2005). This lack of association may be a result of the study cohort or the specific 
language measures employed in our study. 
4.2. Potential caveats and implications  
 
EEG is not a brain structural measure. Evidence has suggested the protective effect of CR is 
expressed in compensatory mechanisms where it would cause certain regions of the brain to 
process information more efficiently and thus compensate for the effects of mild to moderate 
levels of pathology. Brain activity may decrease in damaged regions but increase in other less 
damaged regions or remaining local functional circuits may compensate for the loss of 
neurons within a region (Yaakov Stern, Barnes, Grady, Jones, & Raz, 2019). The lack of a 
CR effect with respect to IAF may mean that IAF is a robust measure of cognition that is 




study the interaction between education and IAF was approaching significance for the Stroop 
interference and Digit ordering task. The interaction between pre-morbid IQ and IAF was 
also approaching significance for Stroop interference. These interaction effects were, 
however, small in terms of effect size. It is possible that these effects would become 
significant if we had a larger sample size, but they suggest that any such effects are likely to 
be small. 
4.3. Limitations  
 
To the best of author’s knowledge, this study is the first to use EEG to examine CR and its 
moderation effect in the context of the PD and only the fifth study to examine CR in the 
context of EEG across any conditions. Several limitations and improvements need mention. 
Perhaps the most important is the quality of the CR proxy. Although education is the most 
commonly used CR proxy, its implementation and influence are variable. Education has 
shown to be beneficial to cognitive ability in some studies but not in others (Bauer et al., 
2020; Premi et al., 2020). Education can be transformed into scales, dichotomised or as a 
continuous variable in the case of the current study. The way education was presented as a 
CR proxy should be evaluated. some studies suggest that the effect of education can only be 
in effect when a certain amount of educational attainment have been achieved. For example, 
the protective effect of Lucero et al. (2015) only present in people with 16 or more years of 
education, so a non-linear evaluation of years of education may be warranted. Their findings 
suggested that a person needs at least a university degree for education to have a CR 
influence. Given the average years of education in our database to be around 13 years, it is 
possible that education in our case did not have the effect of CR because a dichotomy using 
very high vs not very high years of education should be used. However, we would need a 




Nonetheless, education and premorbid IQ are proxies of CR and may not capture all 
aspects of CR (Y. Stern et al., 2018). Other CR contributing factors, such as lifestyle and 
work experience, could be substantially relevant and in some case have a greater influence 
than education or pre-morbid IQ. A better test of CR may require a composite measure 
derived from different sources. An interesting example of a composite measure is CRIq 
(Nucci, Mapelli, & Mondini, 2012). CRIq incorporates factors that are related to education, 
working activity and leisure time. Evidence has suggested that CRIq has a better correlated 
with cognitive impairment and motor dysfunction in PD (Guzzetti et al., 2019).  
IAF is a functional measure of brain activity. Babiloni et al. (2020) found that in AD 
patients, high education may cause abnormal resting-state posterior EEG alpha rhythms in the 
parietal, occipital and temporal regions of the brain, but there was no effect of education on 
the alpha power across the brain. Since the moderating effect of CR may appear in certain 
regions, the analysis could be improved by including different regions. We have evidence 
that IAF in the posterior brain is highly correlated (>0.9) with alpha activity elsewhere, but 
CR specifically may still show regional effects.  
The underlying mechanisms of CR are still unclear. Although the current study has 
yielded no evidence of the moderation effect of CR on the brain, future research could 
consider studies based on other EEG measures and other brain measures. Previous studies 
have suggested that the moderating effect of CR may appear compensatory, so further studies 
are needed to explain any compensation effects (Babiloni et al., 2020; Fleck et al., 2017; 








This study is the first study using EEG to investigate the moderating effect of CR in PD. The 
results highlighted the association between IAF and cognitive abilities. However, there was 
no evidence of a moderating effect of CR when IAF was used as the measure of brain 
integrity and either years of education or pre-morbid IQ were used as proxy measures for CR. 
This study suggests that IAF can be considered a robust marker of cognition, which is not 
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